A detailed history of Le Jeune Puetz Investment Counsel LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Le Jeune Puetz Investment Counsel LLC holds 9,950 shares of ABBV stock, worth $1.76 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
9,950
Previous 9,681 2.78%
Holding current value
$1.76 Million
Previous $1.57 Million 1.28%
% of portfolio
0.58%
Previous 0.6%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $38,900 - $44,799
269 Added 2.78%
9,950 $1.59 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $16,114 - $20,389
150 Added 1.57%
9,681 $1.31 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $228,866 - $259,797
2,151 Added 29.15%
9,531 $1.03 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $10,521 - $11,721
100 Added 1.37%
7,380 $831,000
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $16,097 - $21,734
200 Added 2.82%
7,280 $780,000
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $17,182 - $20,166
200 Added 2.91%
7,080 $620,000
Q2 2020

Aug 03, 2020

SELL
$73.37 - $98.18 $67,500 - $90,325
-920 Reduced 11.79%
6,880 $675,000
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $343,914 - $521,416
5,332 Added 216.05%
7,800 $594,000
Q4 2019

Jan 28, 2020

BUY
$72.13 - $90.25 $178,016 - $222,737
2,468 New
2,468 $219,000
Q3 2019

Oct 23, 2019

SELL
$62.98 - $75.72 $98,752 - $118,728
-1,568 Closed
0 $0
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $122,068 - $150,543
1,568 New
1,568 $145,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Le Jeune Puetz Investment Counsel LLC Portfolio

Follow Le Jeune Puetz Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.